We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
(-15%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-6.34%
Top 10 Holdings %
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$121M |
| 2 |
PTC Therapeutics
PTCT
|
+$81.6M |
| 3 |
Viatris
VTRS
|
+$76.4M |
| 4 |
Target
TGT
|
+$69.6M |
| 5 |
Five Below
FIVE
|
+$60.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Academy Sports + Outdoors
ASO
|
+$66.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.3M |
| 3 |
Ulta Beauty
ULTA
|
+$62.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$59.8M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$58.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.3% |
| 2 | Consumer Staples | 9.22% |
| 3 | Consumer Discretionary | 6.86% |
| 4 | Technology | 3.5% |
| 5 | Communication Services | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mondelez International
MDLZ
$79.9B
| $25.1M | 0.49% |
400,000
+55,000
| +16% | +$3.58M |
|
52
Alphatec Holdings
ATEC
$1.48B
| $23.4M | 0.45% |
2,036,000
-288,000
| -12% | -$3.11M |
|
53
Meta Platforms (Facebook)
META
$1.5T
| $22.2M | 0.43% |
100,000
+60,000
| +150% | +$15M |
|
|
SPPI
54
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $22.1M | 0.43% |
17,100,000
+7,434,244
| +77% | +$6.85M |
|
55
Frontdoor
FTDR
$5.36B
| $20.7M | 0.4% |
692,000
+68,000
| +11% | +$2.27M |
|
56
Freshpet
FRPT
$3.51B
| $20.5M | 0.4% |
+200,000
| New | +$18.8M |
|
57
JPMorgan Chase
JPM
$955B
| $20.4M | 0.4% |
+150,000
| New | +$22.1M |
|
58
Alibaba
BABA
$308B
| $19.6M | 0.38% |
+180,000
| New | +$20.7M |
|
59
Xeris Biopharma Holdings
XERS
$1.4B
| $19.1M | 0.37% |
+7,464,993
| New | +$18.2M |
|
60
Wynn Resorts
WYNN
$10.5B
| $18.8M | 0.36% |
+236,000
| New | +$19.9M |
|
61
Best Buy
BBY
$17.8B
| $18.2M | 0.35% |
+200,000
| New | +$19.8M |
|
62
RH
RH
$3.7B
| $16.3M | 0.31% |
+49,913
| New | +$20M |
|
63
NRX Pharmaceuticals
NRXP
$131M
| $15.3M | 0.3% |
+625,978
| New | +$20.4M |
|
64
Advantage Solutions
ADV
$439M
| $15.3M | 0.3% |
96,000
+20,160
| +27% | +$3.49M |
|
65
Voyager Therapeutics
VYGR
$187M
| $15.2M | 0.29% |
+2,000,000
| New | +$8.92M |
|
66
Intuitive Surgical
ISRG
$133B
| $15.1M | 0.29% |
+50,000
| New | +$14.6M |
|
|
FREE
67
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $12.9M | 0.25% |
1,800,000
+44,000
| +3% | +$394K |
|
68
BioNTech
BNTX
$23.2B
| $12.8M | 0.25% |
75,000
+7,000
| +10% | +$1.18M |
|
69
Aterian
ATER
$5.5M
| $12.7M | 0.25% |
+436,131
| New | +$16M |
|
|
KDNY
70
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $12.4M | 0.24% |
756,000
-280,000
| -27% | -$3.81M |
|
71
Eterna Therapeutics
ERNA
$4.78M
| $11.3M | 0.22% |
+733
| New | +$13.9M |
|
|
EGRX
72
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $11.1M | 0.21% |
+224,000
| New | +$10.8M |
|
73
Spectrum Brands
SPB
$2.09B
| $10.6M | 0.21% |
+120,000
| New | +$11M |
|
74
Boston Beer
SAM
$1.9B
| $10.5M | 0.2% |
27,000
-21,000
| -44% | -$8.76M |
|
75
Dynatrace
DT
$14.8B
| $9.98M | 0.19% |
212,000
+72,000
| +51% | +$3.39M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.
- Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
- Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
- Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
- Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
- Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
- Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
- Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.
Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.